Heart Failure Clinical Trials in Dallas, Texas

30 studies are recruiting for heart failure in Dallas, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies, page 2

1. Cardiopulmonary Stress Testing (CPET) AlloSure Study

   1. Cell-free DNA does not vary significantly as a function of the activity of immunologically quiescent cardiac transplant recipients, despite the metabolic demands of the transplanted organ. (The implication of the null result would be that no restrictions to patient activity, nor modification of …

   Stage

   Not phased

   Ages

   18 and older

   Site

   Baylor Scott & White health research institute, Dallas, Texas

   Run by

   Baylor Research Institute

   See if you can join NCT04656080 on ClinicalTrials.gov

2. Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial

   This is a prospective, double-blind, sham-controlled, multicenter, randomized clinical trial is to study the effects of remote ischemic preconditioning on contrast-associated acute kidney injury, functional capacity, and major adverse kidney events in in patients with congestive heart failure under…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas, Texas

   Locations

   3 in total

   Run by

   VA Office of Research and Development

   See if you can join NCT04982419 on ClinicalTrials.gov

3. Get With The Guidelines-Heart Failure Registry

   Get With The Guidelines-Heart Failure is designed to improve the quality of care in patients hospitalized with heart failure. The program aims to help ensure that eligible patients are initiated on guideline recommended therapies and receive appropriate counseling prior to hospital discharge.

   Stage

   Not phased

   Ages

   18 to 125

   Site

   Amy Bennett, Dallas, Texas

   Run by

   American Heart Association

   See if you can join NCT02693509 on ClinicalTrials.gov

4. Identification of Genomic Predictors of Adverse Events After Cardiac Surgery

   This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate.

   Stage

   Not phased

   Ages

   20 to 90

   Site

   UT Southwestern Medical Center, Dallas, Texas

   Locations

   3 in total

   Run by

   Brigham and Women's Hospital

   See if you can join NCT01258231 on ClinicalTrials.gov

5. Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction

   It is believed that targeted SERCA2a enzyme replacement in HFrEF patients will correct defective intracellular Ca2+ hemostasis, resulting in improved cardiac contractile function and energetics which will, in turn, translate to improved clinical outcomes. Additionally, it is hypothesized that corre…

   Stage

   Phase 1

   Ages

   18 to 80

   Site

   University of Texas Southwestern Medical Center, Dallas, Texas

   Locations

   5 in total

   Run by

   Sardocor Corp.

   See if you can join NCT04703842 on ClinicalTrials.gov